We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Protagen, Inova Announce Agreement for BICD2 Biomarker

News   Aug 12, 2016

 
Protagen, Inova Announce Agreement for BICD2 Biomarker
 
 
Advertisement
 

RELATED ARTICLES

Initial Immune Response Key to Preventing Pandemics

News

New research suggests that a host's initial immune response has a central role in determining whether infection occurs and the degree to which it spreads within a population.

READ MORE

New Technology Transports the Genes for Therapeutic Agents Directly Into Tumor Cells

News

A new technology from UZH researchers enables the body to produce therapeutic agents on demand at exactly the point where they are needed. The innovation could reduce the side effects of cancer therapy and help better deliver COVID-19 treatments to the lungs.

READ MORE

Blood-Based Biomarker Panel Can Distinguish Between Bacterial and Viral Infections

News

Researchers have identified a set of molecular biomarkers that can be used in the differential diagnosis of acute bacterial and viral infections. These biomarkers are different mRNA molecules found in the blood; differences in their levels can detect and predict with high probability if an infection is viral or bacterial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE